An overview of the treatment of Tourette's disorder and tics

Journal of Child and Adolescent Psychopharmacology

Volumn 20, Issue 4, 2010, Pages 249-262

  Párraga, Humberto C ^a   Harris, Kara M ^a   Párraga, Karen L ^a   Balen, George M ^a   Cruz, Cristina ^a  

^a Fourth Street Clinic ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATOMOXETINE; CHLORPROMAZINE; CITALOPRAM; CLONIDINE; CLOZAPINE; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; FLUOXETINE; FLUPHENAZINE; FLUVOXAMINE; GUANFACINE; HALOPERIDOL; LISDEXAMFETAMINE; METHYLPHENIDATE; OLANZAPINE; PAROXETINE; PENFLURIDOL; PERPHENAZINE; PIMOZIDE; PSYCHOSTIMULANT AGENT; RISPERIDONE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; ZIPRASIDONE;

AKATHISIA; ALPHA ADRENERGIC RECEPTOR BLOCKING; BLOOD DYSCRASIA; CHILDHOOD DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DERMATITIS; DOPAMINERGIC SYSTEM; DRUG ANTAGONISM; DRUG EFFICACY; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; GILLES DE LA TOURETTE SYNDROME; HUMAN; LETHARGY; LIVER DYSFUNCTION; MOTOR PERFORMANCE; OUTCOME ASSESSMENT; PHOTOSENSITIVITY; PSYCHOTHERAPIST; REVIEW; RISK ASSESSMENT; SIDE EFFECT; TIC; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; TICS; TOURETTE SYNDROME;

EID: 77956406236     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2010.0027     Document Type: Review

References (128)

1. Abuzzahab FS, Anderson FO: Gilles de la Tourette: International Registry. Minn Med 56:492-496, 1973.
2. Adams JR, Troiano AR, Calne DB: Functional imaging in Tourette's syndrome. J Neural Transm 11:10-11, 2004.
3. Bajo S, Battaglia M, Pegna C, Bellodi L: Citalopram and fluvoxamine in Tourette's disorder Letter. J Am Acad Child Adolesc Psychiatry 38:230-231, 1999.
4. Baker EFW: Gilles de la Tourette's disease treated by biomedial frontal leucotomy. Can Med Assoc J 86:746-747, 1962.
5. Berecz JM, Dysken MW, Davis JM: Naloxone effect in Tourette's syndrome [letter]. Neurology 29:1316-1317, 1979.
6. Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL: Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with Attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther 29:450-460, 2007.
7. Blache R: Chorees graves guerison rapide par les massages et la gymnastique methodique appliques. Rapid treatment of severe choreas by massages and application of methodic gymnastics. Gazette hebdomadaire p.787, 1864.
8. Borison Rl, Ang L, Chang S, Dsyken M, Comaty JE, Davis JM: New pharmacological approaches in the treatment of Tourette's syndrome. In: Advances in Neurology, Vol. 35, Gilles de la Tourette's Syndrome, edited by A.J. Friedhoff, T.N. Chase. New York: Raven Press, 377-382, 1982.
9. Brain WR: The treatment of tics. Lancet 1:1295-1296, 1928.
10. Brissaud E: Choree variable. Press Med 13:73-74, 1899.
11. Bruun RD, Budman CL: Risperidone as a treatment for Tourette's syndrome. J Clin Psychiatry 57:29-31, 1996.
12. Bruun RD: Clonidine treatment of Tourette's syndrome. In: Advances in Neurology, Vol. 35, Gilles de la Tourette Syndrome, edited by A.J. Friedhoff and T.N. Chase. New York: Raven Press, 403-405, 1982.
13. Bubl E, Perlov E, Tebartz Van Elst L: Aripiprazole in patients with Tourette's Sindrome. World Biol J Psychiatry 7:123-125, 2006.
14. Buckingham D, Gaffney G: New Tourette's syndrome treatment. J Am Acad Child Adolesc Psychiatry 32:224, 1993.
15. Burd L, Kerveshian J, Fisher W, Gascon G: Anticonvulsant medications: An iatrogenic cause of tic disorders. Can J Psychiatry 31:419-423, 1986.
16. Caine ED, Polinsky RJ, Ebert MH, Rapaport JL, Mikkelsen EJ: Trial of clomipramine and desipramine for Tourette's syndrome. Ann Neurol 5:305, 1979a.
17. Caine ED, Polinsky RJ, Kartzinel R, Ebert M: The trial use of clo-zapine for abnormal involuntary movement disorders. Am J Psychiatry 136:317-320, 1979b.
18. Castellanos FX, Giedd JN, Elia J, Marsh WL, Ritchie GF, Hamburger SD, Rapoport JL: Controlled stimulant treatment of ADHD and comorbid Tourette's: Effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 36:589-596, 1997.
19. Challas G, Brauer W: Relief of symptoms with R1625. Am J Psychiatry 120:283-284, 1963.
20. Chapel JL, Brown N, Jenkins RL: Tourette's disease: Symptomatic relief with haloperidol. Am J Psychiatry 121:608-610, 1964.
21. Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A: Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: Preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 34:1140-1146, 1995.
22. Charcot JM: Lecons du Mardi a la Sarpetriere. Tuesday lessons at the Sarpetriere. Polyclinique 2:13-17, 1888.
23. Clark DF: Behavior therapy of Gilles de la Tourette's syndrome. Brit J Psychiat 112:771-778, 1966.
24. Cohen DJ, Detlor J, Young JG, Shaywitz BA: Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry 37:1350-1357, 1980.
25. Cohen DJ, Shaywitz BA, Caparulo B, Young JG, Bowers MB Jr.: Chronic multiple tics of Gilles de la Tourette's disease. Arch Gen Psychiatry 35:245-250, 1978.
26. Comings BG, Comings DE: A controlled study of Tourette's syndrome: Attention deficit disorders and school problems. Am J Hum Genet 41:701-741, 1987.
27. Como PG, Kurlan R: An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome. Neurology 6:872-874, 1991.
28. Cruchet R: Etude critique sur le tic convulsif et son traitement gym-nastique. Critical study on convulsive tic and its gymnastic. These de Bordeaux, 1902.
29. Debray P, Messerschmitt P, Lonchap D, Herbault M: L'utilization du pimozide en pedopsychiatrie. The use of pimozide in pediatric psychiatry. Nouv Press Med 1:2917-2918, 1972.
30. Denckla MB, Bemporad JR, McKay MC: Tics following methyl-phenidate administration. A report of 20 cases. JAMA 235:13791381, 1976.
31. Dillon DC, Salzman IJ, Schulsinger DA: The use of imipramine in Tourette's syndrome and attention deficit disorder: Case report. J Clin Psychiatry 46:348-349, 1985.
32. Dion Y, Annable L, Sabdor P, Chouinard G: Risperidone in the treatment of Tourette's syndrome: a double-blind, placebo controlled trial. J Clin Psychopharmacol 22:31-39, 2002.
33. Downing RW, Comer NL, Ebert JN: Family dynamics in a case of Gilles de la Tourette's syndrome. J Nerv Ment Dis 138:548-557, 1964.
34. Erickson MH: Experimental hypnotherapy in Tourette's disease. Am J Clin Hypnother 7:325-331, 1964.
35. Faux EJ: Gilles de la Tourette's syndrome: Social psychiatric management. Arch Gen Psychiatry 14:139-142, 1966.
36. Feigin A, Kurlan R, McDermott MP, Beach H, Dimitsopulos T, Brower CA, Chapieski L, Trinidad K, Como P, Jankovic J: A control trial of deprenyl in children with Tourette's syndrome and attention-deficit hyperactivity disorder. Neurology 46:965-968, 1996.
37. Feinberg M, Carroll BJ: Effects of dopamine agonists and antagonists in Tourette's disease. Arch Gen Psychiatry 36:979-985, 1979.
38. Frandenburg FR, Kando JC: Sertraline treatment of attention deficit hyperactivity disorder and Tourette's syndrome. J Clin Psychopharmacol 14:359-360, 1994.
39. Fras I: Gilles de la Tourette's syndrome: Effects of tricyclic antidepressants. NY J Med 78:1230-1232, 1978.
40. Fras I, Karlavage J: The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children. Am J Psychiatry 134:195-197, 1977.
41. Gadow KD, Nolan EE, Sverd J: Methylphenidate in hyperactive boys with comorbid tic disorder. II. Short-term behavioral effects in school settings. J Am Acad Child Adolesc Psychiatry 31:462-471, 1992.
42. Gadow KD, Sverd J, Sprafkin J, Nolan EE, Grossman S: Long-term methylphenidate therapy in children with comorbid ADHD and chronic multiple tic disorder. Arch Gen Psychiatry 56:330-336, 1999.
43. Gadow KD, Sverd J, Sprafkin J: Efficacy of methylphenidate for attention deficit hyperactivity disorder in children with tic disorder. Arch Gen Psychiatry 52:444-455, 1995.
44. Gadow KD, Sverd J: Stimulants for ADHD in child patients with Tourette's syndrome: The issue of relative risk. J Dev Behav Pe-diatr 11:269-271, 1990.
45. George MS, Sallee FR, Nahas Z, Oliver NC, Wasserman EM: Tran-scranial magnetic stimulation (TMS) as a research tool in Tourette syndrome and related disorders. Adv Neurol 85:225-235, 2001.
46. Ghanizadeh A: The emergence of echolalia while taking sertraline in a patient with Tourette's syndrome. Dev Med Child Neurol 50:398399, 2008.
47. Gilles de la Tourette G: Etude sur une affection nerveuse characterisee par de l'incoordination motrice accompagnee d'echolalie et de coprolalie. Study of a nervous affection characterized by motor uncoordination accompanied by echolaly and coprolaly. Arch Neurol 25:10-41, 1885.
48. Goetz CG, Tanner CM, Klawans HL: Fluphenazine and multifocal tic disorders. Arch Neurol 41:271-272, 1984.
49. Goetz CG, Tanner CM, Wilson RS, Shannon KM: A rating scale for Gilles de la Tourette's syndrome: Description, reliability and treatment. Neurology 37:1542-1544, 1987.
50. Golden GS: Gilles de la Tourette's syndrome following methylphenidate administration. Dev Med Child Neurol 16:76-78, 1974.
51. Golden GS: The effect of the central nervous systems stimulants on Tourette syndrome. Ann Neurol 2:69-70, 1977.
52. Guinon G: Tic convulsifs et hysterie. Convulsive tics and hysteria. Rev Med 7:509-519, 1887.
53. Hamra BJ, Dunner FH, Larson C: Remission of tics with lithium therapy: Case report. J Clin Psychiatry 44:73-74, 1983.
54. Horrigan PJ, Barhill LJ: Paroxetine-pimozide drug interaction (Letter). J Am Acad Child Psychiatry 33:1060-1061, 1994.
55. Itard JMG: Memoire sur quelques fonctions involuntaires des appa-reils de la locomotion, de la prehension et de la voix, 1825.
56. Jankovic J, Beach J: Long-term effects of tetrabenazine in hyperkinec movement disorders. Neurology 48:358-362, 1997.
57. Jankovic J, Jimenez-Shahed J, Brown LW: A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry 81:70-73, 2010.
58. Jankovic J: Botulinum toxin in the treatment of dystonic tics. Mov Disord 9:347-349, 1994.
59. Konkol RJ, Fisher M, Newby RF: Double-blind, placebo controlled stimulants trial in children with Tourette's syndrome and attention-deficit disorder. Ann Neurol 28:424, 1990.
60. Law SF, Schachar RJ: Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 38: 944-951, 1999.
61. Leckman JF, Detlor J, Harcherik DF, Ort S, Shaywitz BA, Cohen DJ: Short and long-term treatment of Tourette's syndrome with clonidine: A clinical perspective. Neurology 35:343-351, 1985.
62. Leckman JF, Zhang H, Vitale A, Lahnin F, Lynch K, Bondi C, Kim YS, Peterson BS: Course of tic severity in Tourette's syndrome: The first two decades. Pediatrics 12:14-19, 1998.
63. Lee TS, Lee D, Lombroso PJ, King R: Atomoxetine and tics in ADHD. J Am Acad Child Adolesc Psychiatry 43(9): 1068-1069, 2005.
64. Lombroso PJ, Scahill L, King RA, Lynch KA, Chappell PB, Peterson BS, McDougle CJ, Leckman JF: Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report. J Am Acad Child Adolesc Psychiatry 34:1147-1152, 1995.
65. Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz BA: Stimulant medications precipitate Tourette's syndrome. JAMA 247:1729-1731, 1982. (Pubitemid 12192968)
66. Mahler MS, Gross IH: Psychotherapeutic study of a typical case with tics syndrome. Nerv Child 4:359-373, 1945.
67. Mahler MS, Luke JA: Outcome of the tic syndrome. J Nerv Ment Dis 103:433-445, 1946.
68. Mahler MS, Rangell L: A psychosomatic study of maladie des tics (Gilles de la Tourette's disease). Psychiatr Q 17:579-603, 1943.
69. McCracken J, Sallee FR, Leonard H: Improvement of ADHD by atomoxetine in children with tic disorders. Presented at American Academy of Child and Adolescent Psychiatry, October 14-19, Miami, FL, 2003.
70. McCracken JT, Suddath R, Chang S, Thakur S, Piacentini J: Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette's syndrome. J Child Adolesc Psycho-pharmacol 18:501-508, 2008.
71. McDonald IJ: A case of Gilles de la Tourette's Syndrome with some etiological observations. Brit J Psychiatry 109:206-210, 1963.
72. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH: The efficacy of fluvoxamine in obsessive-compulsive disorder: Effects of comorbid chronic tic disorder. J Clin Psycho-pharmacol 13:354-358, 1993.
73. Meige H, Feindel E: Les Tics et leur traitement. Paris: Masson, 1902.
74. Meige H, Feindel E: Tics and Their Treatment, Translated and edited by SAK Wilson. New York: William Wood and Co., 1907.
75. Messiha FS, Knopp W: A study of endogenous dopamine metabolism in Gilles de la Tourette disease. Dis Nerv Syst 37:470-475, 1976.
76. Mikkelsen EJ, Detlor J, Cohen DJ: School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder. Am J Psychiatry 138:1572-1576, 1981.
77. Mitchell E, Mattews KL: Gilles de la Tourette's disorder associated with pemoline. Am J Psychiatry 137:1618-1619, 1980.
78. Moldofsky H, Sandor P: Lecithin in the treatment of Gilles de la Tourette's syndrome. Am J Psychiatry 140:1627-1629, 1983.
79. Murphy TK, Bengston MA, Soto O, Edge PJ, Sajid MW, Shapira N, Yang M: Case series on the use of aripiprazole for Tourette's Syndrome. Int J Neuropsychopharmacol 25:94-96, 2005.
80. Nelson TY, Bost MT, Lesser PS: Topiramate in children and adolescents with Tourette syndrome: A case series. J Pediatric Neurol 5:15-19, 2007.
81. Palumbo D, Spencer T, Lynch J: Co-Chien H, Faraone SV: Emergence of tics in children with ADHD: Impact of once-daily OROS methylphenidate therapy. J Child Adolesc Psychopharmacol 14:185-194, 2004.
82. Parihk MD, Abhyanka RR, Bajaj N, Doongaji DR: Penfluridol in the treatment of Gilles de la Tourette's syndrome. Neurology 27:174177, 1979.
83. Parraga HC, Cochran M: Emergence of motor and vocal tics during imipramine administration in two children. J Child Adolesc Psy-chopharmacol 3:227-234, 1992.
84. Parraga HC, Parraga M, Woodward R, Fenning P: Quetiapine Treatment of children with Tourette's syndrome: Report of two cases. J Child Adolesc Psychopharmacol 11:187-191, 2001.
85. Perlmutter SJ, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL, Swedo SE: Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354:1153-1158, 1999.
86. Pfeiffer C, Wagner ML: Clozapine therapy for Parkinson's disease and other movement disorders. Am J Hosp Pharm 51:3047-3053, 1994.
87. Piacentini J, Woods D, Scahill L, Wilhelm S, Peterson A, Chang S, Ginsburg G, Deckersbach T, Dziura J, Levi-Pearl S, Walkup J: Behavior therapy for children with Tourette disorder: A randomized controlled trial. JAMA 303:1929-1937, 2010.
88. Pollak MA, Cohen NL, Friedhoff AJ: Gilles de la Tourette's syndrome: Familial occurrence and precipitation by methylphenidate therapy. Arch Neurol 34:630-632, 1977.
89. Popielarska HC, Werry JS: Psychopathological Disorders of Childhood. New York: Wiley, 1972.
90. Price RA, Leckman JF, Pauls DL,Cohen DJ, Kidd KK: Gilles de la Tourette's syndrome: Tics and central nervous system stimulants in twins and non twins. Neurology 36:232-237, 1986
91. Ratzoni G, Hermesch H, Brandt N, Lauffer M, Munitz H: Clomi-pramine efficacy in tics, obsessions and compulsions in Tourette's syndrome and obsessive compulsive disorder: A case study. Biol Psychiatry 27:95-98, 1990.
92. Regeur L, Pakkenberg B, Fog R, Akkenberg H: Clinical features and long term treatment with Pimozide in 65 patients with Gilles de la Tourette's syndrome. J Neurol Neurosurg Psychiatry 99:791-795, 1986.
93. Riddle MA, Hardin MT, Cho SC, Woolston JL, Leckman JF: Desi-pramine treatment of boys with attention-deficit hyperactivity disorder and tics. Preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 27:811-814, 1988.
94. Sallee FR, Kurlan R, Goetz CG, Sinmger H, Singer H, Scahill L, Law G, Dittman VM, Chapell PB: Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study. J Am Acad Child Adolesc Psychiatry 39:292-299, 2004.
95. Sallee FR, Nesbitt l, Jackson C, Sine L, Sethuraman G: Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 154:1057-1062, 1997.
96. Salloway S, Stewart CF, Israeli I: Botulinum toxin for refractory vocal tics. Mov Disord 11:746-748, 1996.
97. Sandyk R, Bamford CR: Beneficial effects of imipramine on Tour-ette's syndrome. Int J Neurosci 39:27-29, 1988.
98. Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten A Cohen DJ, Leckman JF: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158:10671074, 2001.
99. Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS: A placebo controlled trial of risperdone in Tourette's Syndrome. Neurology 60:1130-1135, 2003.
100. Seignot MJN: Un cas de maladie des tics de Gilles de la Tourette gueri par le R-1625. A case of Gilles de la Tourette's disease treated with R-1625. Ann Med Psychol 119:578-579, 1961.
101. Shapiro AK, Shapiro E: Controlled study of pimozide vs. placebo in Tourette's syndrome. J Am Acad Child Psychiatry 23:161-173, 1984.
102. Shapiro AK, Shapiro E: Do stimulants provoke, cause or exacerbate tics and Tourette syndrome? Comp Psychiatry 22:265-273, 1981.
103. Shapiro AK, Shapiro E, Eisenkraft GJ: Treatment of Tourette's disorder with penfluridol. Compr Psychiatry 24:327-331, 1983a.
104. Shapiro AK, Shapiro E, Eisenkraft GJ: Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics. Arch Gen Psychiatry 40:1235-1240, 1983b. (Pubitemid 13015020)
105. Shapiro AK, Shapiro E, Wayne HL: Treatment of Gilles de la Tour-ette's syndrome with haloperidol: Review of 34 cases. Arch Gen Psychiatry 28:92-96, 1973.
106. Shapiro AK, Shapiro E, Young JG, Feinberg TE: Gilles de la Tourette's Syndrome, 2nd edition. New York: Raven Press, 387-390, 1988.
107. Shapiro AK, Shapiro ES, Bruun RD, Sweet RD: Gilles de la Tourette's Syndrome. New York: Raven Press, 119-141, 1978.
108. Silva R, Muniz R, Pestreich L, Brams M, Mao A, Childress A, Wang J: Dexmethylphenidate extended-release capsules in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 47: 199-208, 2008.
109. Silver AA, Shytle RD, Sanberg PA: Clinical Experience with trans-dermal nicotine patch in Tourette syndrome. CNS Spectrums 4:6876, 1999.
110. Silvestri R, Raffaele M, De Domenico P, Tisano A, Lagana A, Di Perri R: Serotoninergic agents in the treatment of Gilles de la Tourette's syndrome. Acta Neurol 49:58-63, 1994.
111. Singer HS, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla MB: The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: A double-blind placebo controlled study with clonidine and desipramine. Pediatrics 95:74-81, 1995.
112. Singer HS, Wendlandt J, Krieger M, Giuliano J: Baclofen treatment in Tourette's syndrome: A double-blind, placebo-controlled, crossover trial. Neurology 56:599-604, 2001.
113. Singer K: Gilles de la Tourette's Disease. Am J Psychiatry 120:80-81, 1963.
114. Sotero de Menezez MA, Rho JM, Murphy P, Cheyette S: Lamo-trigine-induced tic disorder: report of five pediatric cases. Epilepsy 41:862-867, 2000.
115. Spencer T, Biederman J, Kerman K, Steingard R, Wilens T: Desi-pramine treatment of children with attention deficit hyperactivity disorder and tic disorder or Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 32:354-360, 1993a. (Pubitemid 23099642)
116. Spencer T, Biederman J, Wilens T, Steingard R, Geist D: Nortripty-line treatment of children with attention deficit hyperactivity disorder and tic disorder or Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 32:205-210, 1993b. (Pubitemid 23052921)
117. Stephens RJ, Bassel C, Sandor P: Olanzepine in the treatment of aggression and tics in children with Tourette's syndrome-A pilot study. J Child Adolesc Psychopharmacol 14:255-266, 2004.
118. Sverd J, Cohen S, Camp JA: Effects of propranolol in Tourette syndrome. J Autism Dev Disor 13:207-213, 1983.
119. Sverd J: Imipramine treatment of panic disorder in a boy with Tourette's syndrome. J Clin Psychiatry 49:31-32, 1988.
120. Trousseau A: Clinique medicale de l'hotel Dieu de Paris quatrieme edition. Medical clinic at Dieu's hotel in Paris, Fourth edition. Paris: Balliere, 3, 1873.
121. Van der Linden C, Colle H, Vanderwalle V, Alessi G, Rijckaert D, De Waele L: Successful treatment of tics with bilateral internal pallidum (GPi) stimulation in a 27 year old male patient with Gilles de la Tourette's syndrome. Mov Disord 17:1130, 2002.
122. Vance CK, Kanner AM, Smith MC: Sydenham's-like picture and touretism as related to lamotrigine toxicity. Epilepsy 45 (Suppl 7):137, 2004.
123. Vanderwalle V, van der Linden C, Groenewegen HJ, Caemaert J: Stereotactic treatment of Gilles de la Tourette's syndrome by high frequency stimulation of thalamus. Lancet 353:724, 2001.
124. Voulter L, Bressamn SB, Fahn S: Treatment of tic disorder with clonazepam. J Can Sci Neurol 12:172-173, 1985.
125. Walsh TL, Lavenstein B, Licamele WL, Bronheim S, O'Leary JO: Calcium antagonists in the treatment of Tourette's disorder. Am J Psychiatry 143:1467-1468, 1986.
126. Yaryura-Tobias JA: Clomipramine in Gilles de la Tourette disease. Am J Psychiatry 132-1221, 1975.
127. Yaryura-Tobias JA, Neziroglu FA: Gilles de la Tourette syndrome: A new clinico-therapeutic approach. Prog Neuropsychopharmacol 1:355-358, 1977.
128. Zawadski A: Treatment of Maladie des tics with carbamazepine. Pediatri Pol 47:1105-1110, 1972.